NEPHROS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NEPHROS, INC. (NEPH) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-12
- NEPHROS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.10M, a 0.00% change from fiscal 2024.
- NEPHROS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.10M, a 0.00% change from fiscal 2023.
- NEPHROS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.10M, a 35.29% decline from fiscal 2022.
- NEPHROS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.70M, a 0.00% change from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $1.10M 10-K · filed 2026-03-12 | $1.00M 10-K · filed 2025-03-24 |
| 2023-12-31 | $1.10M 10-K · filed 2024-03-15 | |
| 2022-12-31 | $1.70M 10-K · filed 2023-03-23 | |
| 2021-12-31 | $1.70M 10-K · filed 2023-03-23 | $691.00K 10-K · filed 2022-03-03 |
| 2020-12-31 | $691.00K 10-K · filed 2022-03-03 | $166.00K 10-K · filed 2021-03-01 |
| 2019-12-31 | $676.00K 10-K · filed 2020-02-27 | |
| 2018-12-31 | $797.00K 10-K · filed 2019-03-12 | |
| 2017-12-31 | $12.07M 10-K · filed 2018-02-26 | |
| 2016-12-31 | $983.48K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |